XML 23 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:    
Net loss from continuing operations $ (32,275,070) $ (8,235,449)
Net loss from discontinued operations (3,422,225)
Net loss for the year (32,275,070) (11,657,674)
Adjustments for non-cash items:    
Loss on loss of control of Bophelo Bio, net of cash surrendered 2,375,840
Gain on bargain purchase (12,760,356)
Share based payments to social development trust 2,124,615
Depreciation and amortization 4,283,731 3,763,321
Change in fair value of biological assets 140,088 (1,216,130)
Change in fair value of financial asset at fair value through profit or loss 264,655 516,281
Stock-based compensation 559,225
Interest expenses 237,319 210,996
Fair value of RSUs exercised, net of cancelled shares 839,896 2,498,754
Gain on settlement on debt (113,037) (67,075)
Loss on disposal of asset 4,495
Write-off of AP, net (2,697,719)
Impairment loss 24,665,564
Working capital adjustments (net of amounts acquired/disposed):    
Trade and other receivables 973,382 (591,072)
Prepayments 64,635 (709,124)
Inventory 482,716 501,706
Trade and other payables 1,537,397 2,915,276
Due to related parties 91,374 66,021
Cash flows used in operating activities (1,500,574) (11,469,396)
Cash flows from investing activities:    
Acquisition of Holigen, net of cash acquired and holdback (2,366,609)
Purchase of financial assets at fair value through profit or loss (801,160)
Additions to property, plant and equipment (1,502) (310,946)
Cash surrendered on loss of control of Bophelo Bio Sciences (739,947)
Loan receivable (84,020)
Proceeds from disposal of property, plant and equipment 110,410
Cash flows provided by (used in) investing activities 24,888 (4,218,662)
Cash flows from financing activities:    
Proceeds from IPO, net of costs 14,654,593
Proceeds from private placement, net of costs 278,482
Advances from related parties 1,570,145
Loans received 742,591 501,217
Loans repaid (766,169) (649,661)
Lease payments (60,000) (645,995)
Cash flows provided by financing activities 1,486,567 14,138,636
Net increase (decrease) in cash and cash equivalents 10,881 (1,549,422)
Effects of exchange rate changes on cash and cash equivalents (172,809) (1,690,165)
Cash and cash equivalents at the beginning of the year 255,803 3,495,390
Cash and cash equivalents at the end of the year $ 93,875 $ 255,803